Trinity Biotech plc (Trinity Biotech), is an Ireland-based company that develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The Company is a provider of raw materials to the life sciences industry and research institutes globally through the Company subsidiary, Fitzgerald Industries. Trinity Biotech markets its portfolio of over 400 products to customers in 110 countries around the world. Trinity Biotech has manufacturing facilities in Bray, Ireland, in Jamestown, New York, Carlsbad, California and Kansas City, Missouri in the United States. On July 26, 2013, it acquired Immco Diagnostics Inc.
|Headquarters||IDA Business Park|
BRAY, Ireland 18
|Executive Chairman of the Board||Ronan O'Caoimh|
|Chief Financial Officer, Secretary||Kevin Tansley|
|Chief Operating Officer, Executive Director||Rory Nealon|
|Chief Scientific Officer, and Vice President Cardiac||Eric Brouwer|
|Executive Director||James Walsh|
|Shares Out.||23.7M||Book Value||$8.52|
|Annual Dividend Rate||0.22 USD||Price/Sales (TTM)||3.6|
|Ex-Div Date||6/6/14||P/Cash Flow (TTM)||--|
|Pay Date||7/1/14||Operating Margin||17.00%|
*GAAP = prior to non-GAAP analyst adjusted earnings.